| Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies H Yang, S Kurtenbach, Y Guo, I Lohse, MA Durante, J Li, Z Li, H Al-Ali, ... Blood, The Journal of the American Society of Hematology 131 (3), 328-341, 2018 | 175 | 2018 |
| Progress towards a public chemogenomic set for protein kinases and a call for contributions DH Drewry, CI Wells, DM Andrews, R Angell, H Al-Ali, AD Axtman, ... PLoS ONE, 2017 | 162 | 2017 |
| The mTOR substrate S6 kinase 1 (S6K1) is a negative regulator of axon regeneration and a potential drug target for central nervous system injury H Al-Ali, Y Ding, T Slepak, W Wu, Y Sun, Y Martinez, XM Xu, VP Lemmon, ... Journal of neuroscience 37 (30), 7079-7095, 2017 | 103 | 2017 |
| The kinase chemogenomic set (KCGS): an open science resource for kinase vulnerability identification CI Wells, H Al-Ali, DM Andrews, CRM Asquith, AD Axtman, I Dikic, ... International journal of molecular sciences 22 (2), 566, 2021 | 91 | 2021 |
| Cmc1p Is a Conserved Mitochondrial Twin CX9C Protein Involved in Cytochrome c Oxidase Biogenesis D Horn, H Al-Ali, A Barrientos Molecular and cellular biology 28 (13), 4354-4364, 2008 | 72 | 2008 |
| Rational polypharmacology: systematically identifying and engaging multiple drug targets to promote axon growth H Al-Ali, DH Lee, MC Danzi, H Nassif, P Gautam, K Wennerberg, ... ACS chemical biology 10 (8), 1939-1951, 2015 | 70 | 2015 |
| In vitro models of axon regeneration H Al-Ali, SR Beckerman, JL Bixby, VP Lemmon Experimental neurology 287, 423-434, 2017 | 67 | 2017 |
| Enhancement of BDNF expression and memory by HDAC inhibition requires BET bromodomain reader proteins GC Sartor, AM Malvezzi, A Kumar, NS Andrade, HJ Wiedner, SJ Vilca, ... Journal of Neuroscience 39 (4), 612-626, 2019 | 63 | 2019 |
| Ex-vivo sensitivity profiling to guide clinical decision making in acute myeloid leukemia: A pilot study RT Swords, D Azzam, H Al-Ali, I Lohse, CH Volmar, JM Watts, A Perez, ... Leukemia Research 64, 34-41, 2018 | 62 | 2018 |
| Prediction of protein‐glucose binding sites using support vector machines H Nassif, H Al‐Ali, S Khuri, W Keirouz Proteins: Structure, Function, and Bioinformatics 77 (1), 121-132, 2009 | 50 | 2009 |
| Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome JJ Kim, JM David, SS Wilbon, JV Santos, DM Patel, A Ahmad, ... EBioMedicine 63, 2021 | 46 | 2021 |
| Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome X Liu, GM Ducasa, SK Mallela, JJ Kim, J Molina, A Mitrofanova, ... Kidney international 98 (5), 1275-1285, 2020 | 46 | 2020 |
| Phenotypic screening combined with machine learning for efficient identification of breast cancer-selective therapeutic targets P Gautam, A Jaiswal, T Aittokallio, H Al-Ali, K Wennerberg Cell chemical biology 26 (7), 970-979. e4, 2019 | 46 | 2019 |
| The evolution of drug discovery: from phenotypes to targets, and back H Al-Ali MedChemComm 7 (5), 788-798, 2016 | 45 | 2016 |
| The conserved mitochondrial twin Cx9C protein Cmc2 Is a Cmc1 homologue essential for cytochrome c oxidase biogenesis D Horn, W Zhou, E Trevisson, H Al-Ali, TK Harris, L Salviati, A Barrientos Journal of Biological Chemistry 285 (20), 15088-15099, 2010 | 44 | 2010 |
| A structure-function study of MID1 mutations associated with a mild Opitz phenotype. ELJ Mnayer L, Khuri S, Merheby HA, Meroni G Mol Genet Metab 87 (3), 198-203, 2006 | 44 | 2006 |
| Chemical interrogation of the neuronal kinome using a primary cell-based screening assay H Al-Ali, SC Schürer, VP Lemmon, JL Bixby ACS chemical biology 8 (5), 1027-1036, 2013 | 39 | 2013 |
| Myelin and non-myelin debris contribute to foamy macrophage formation after spinal cord injury CB Ryan, JS Choi, H Al-Ali, JK Lee Neurobiology of disease 163, 105608, 2022 | 36 | 2022 |
| Biophysical characterization reveals structural disorder in the developmental transcriptional regulator LBH H Al-Ali, ME Rieger, KL Seldeen, TK Harris, A Farooq, KJ Briegel Biochemical and biophysical research communications 391 (1), 1104-1109, 2010 | 35 | 2010 |
| Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome M Ge, J Molina, JJ Kim, SK Mallela, A Ahmad, JV Santos, H Al-Ali, ... Elife 12, e83353, 2023 | 34 | 2023 |
Vance P LemmonUniv. of Miami, Case Western Reserve University, Univ. of Pittsburgh, Medical Univ. of SouthEmail được xác minh tại miami.edu